Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study
PCI is an independent prognostic indicator in patients with advanced ovarian cancer receiving secondary cytoreduction surgery. The addition of HIPEC offers a significant survival advantage, particularly in patients with high PCI, when performed at experienced centers in carefully selected cases.
Authors
- Nima Ahmadi
- Shoma Barat (ORCID: https://orcid.org/0000-0002-8879-4276)
- Ruwanthi Wijayawardana
- Winston Liauw (ORCID: https://orcid.org/0000-0002-8631-374X)
- David L. Morris (ORCID: https://orcid.org/0000-0001-9377-8521)
Institutions
- Sutherland Hospital (AU)
- UNSW Sydney (AU)
- St George Hospital (AU)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17779
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00